Clinical Trials
Phase 1/2 study in patients with locally advanced and/or metastatic solid tumors
Conditions: Ovarian cancer, primary peritoneal carcinoma, fallopian tube cancer, endometrial cancer, non-small cell lung cancer, mesothelioma, triple negative breast cancer, HER2-negative breast cancer, hormone receptor-positive breast cancer
Status: Recruiting
Start date: November 2022
